New antibody drug targets kidney damage in lupus patients

NCT ID NCT06064929

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study tests a drug called felzartamab in 14 people with active lupus nephritis, a kidney condition caused by lupus. The drug is a lab-made antibody designed to lower harmful antibody buildup in the kidneys. The main goal is to check safety and how the drug works in the body, while all participants continue their usual treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

felzartamab (a lab-made antibody given by IV)

What this could lead to

If it works, this could point toward a new treatment option for lupus nephritis that helps reduce kidney damage.

What could go wrong

This is a very early, small Phase 1b trial with only 14 people, so results may not apply to everyone. The main goal is safety, not yet proof of effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lupus nephritis systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Accurate Clinical Research - Katy

    Katy, Texas, 77449, United States

  • CEMIC

    CABA, Buenos Aires F.D., C1431FWO, Argentina

  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)

    Montreal, Quebec, H2X 3J4, Canada

  • ClinCept, LLC/River City Vascular Specialists LLC

    Columbus, Georgia, 31904, United States

  • Clinica Priv Velez Sarsfield

    Córdoba, Córdoba Province, X5016, Argentina

  • Georgia Nephrology - Lawrenceville

    Lawrenceville, Georgia, 30046, United States

  • Hospital Britanico de Buenos Aires

    Caba, Buenos Aires F.D., C1280AEB, Argentina

  • Joseph S. and Diane H. Steinberg Ambulatory Care Center

    Brooklyn, New York, 11201, United States

  • Monash Health

    Melbourne, Victoria, 3168, Australia

  • Precision Comprehensive Clinical Research Solutions - Grapevine

    Grapevine, Texas, 76051, United States

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, 4102, Australia

  • Prolato Clinical Research Center

    Houston, Texas, 77054, United States

  • R & H Clinical Research

    Katy, Texas, 77450, United States

  • SUNY Downstate Medical Center

    Brooklyn, New York, 11203, United States

  • St. Paul's Hospital

    Vancouver, British Columbia, V6Z1Y6, Canada

  • Stanford University Medical Center

    Stanford, California, 94305, United States

  • The Ohio State University (OSU)

    Columbus, Ohio, 43210, United States

  • University Health Network - Toronto General Division

    Toronto, Ontario, MST258, Canada

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, 44106, United States

  • University of California, San Diego (UCSD)

    La Jolla, California, 92037, United States

  • University of California, San Francisco (UCSF)

    San Francisco, California, 94143, United States

  • University of Michigan

    Ann Arbor, Michigan, 48109, United States

  • Western Health

    Saint Albans, Victoria, 3021, Australia

  • Westmead Hospital

    Westmead, New South Wales, 2145, Australia